Applied Therapeutics interim CEO sells shares worth $13,999
Leslie D. Funtleyder, the Interim Chief Executive Officer and Chief Financial Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), recently sold 22,950 shares of the company's common stock. The shares ...
Drugmaker to study pig kidney transplants in humans with groundbreaking trial
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
Zacks.com on MSN15h
UTHR or ZTS: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for ...
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option
Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital ...
URTH: How Will Tariffs (Truly) Impact Global Stock Markets
Shares MSCI World ETF tracks global growth and key sectors like tech and real estate. Read why URTH stock could be affected ...